HomeTagsClinical Trials

Clinical Trials

PBGENE-DMD Enters Clinical Trials: First Patient Dosed in Duchenne Gene-Editing Study

Precision BioSciences Announced the Start of Phase 1/2a (FUNCTION-DMD) Study of PBGENE-DMD in Ambulatory Patients with Duchenne

Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy

Entrada Therapeutics Announced It will Report Data from its Exon Skipping Studies in 2026

Satellos Announced the Start of Phase 2A (BASECAMP) Study of SAT-3247 in Ambulatory Patients with Duchenne

China-Based Ractigen Therapeutics is Initiating Clinical Trials to Investigate The Safety and Tolerability of RAG-18 in Patients with DMD

Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy

WVE-N531 Exon Skipping Therapy Phase 2 Clinical Trial Begins for Duchenne Muscular Dystrophy

SPOT-mRNA03 Gene Therapy for Duchenne Muscular Dystrophy Begins Early Phase 1 Clinical Trial

12 Page 1 of 2

Popular

Frequently Asked Questions About Elevidys Used for DMD

Can Ekinci - August 21, 2026

Must Read

CRISPR GuideX Tool: hfCas12Max in CRISPR-Based Therapeutics

Care Guidelines

Breathing Exercises in Duchenne Muscular Dystrophy: Respiratory Therapy, Pulmonary Care & Lung Support

BioMarin Launches BMN 351 Exon 51 Skipping Therapy Phase 2 Clinical Trial for Duchenne Muscular Dystrophy

About us

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Latest Articles

What Is Exon Deletion? Understanding Exon Deletions in Duchenne Muscular Dystrophy

DMD September 2, 2026 0

What is exon deletion, and why does it matter...

tRNA Research for Nonsense Mutations Offers New Hope for Genetic Disorders

Research August 30, 2026 0

Researchers at the University of Toronto, University Health Network...

PBGENE-DMD Enters Clinical Trials: First Patient Dosed in Duchenne Gene-Editing Study

Research August 24, 2026 0

Precision BioSciences has reached an important milestone in Duchenne...

Most Popular

Frequently Asked Questions About Elevidys Used for DMD

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

© 2024 - 2026 DMD Warrior. All rights reserved.